The HMGA2 ability to accelerate the cell cycle by enhancing E2F activity and promoting cyclin B expression is in agreement with former data that have reported the development of pituitary tumors in engineered mouse models bearing mutation in cell cycle master regulator genes, such as p27Kip1 and RB [61]. Here, CDKN1B is linked to pituitary tumor.